Intuitive Surgical (ISRG) Stock Forecast & Price Target

Compare

7,819 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ISRG Analyst Ratings

Strong Buy

18 Buy

2 Hold

1 Sell

Based on 21 analysts giving stock ratings to

Intuitive

Surgical

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ISRG Stock 12 Month Forecast

Average Price Target

$596.35

▲(11.74%Upside)

Based on 21 Wall Street analysts offering 12 month price targets for Intuitive Surgical in the last 3 months. The average price target is $596.35 with a high forecast of $675.00 and a low forecast of $440.00. The average price target represents a 11.74% change from the last price of $533.71.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"401":"$401","676":"$676","469.75":"$469.8","538.5":"$538.5","607.25":"$607.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":675,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$675.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":596.35,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$596.35</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":440,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$440.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[401,469.75,538.5,607.25,676],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,553.29,562.6523076923077,572.0146153846154,581.376923076923,590.7392307692307,600.1015384615384,609.4638461538461,618.8261538461538,628.1884615384615,637.5507692307692,646.9130769230769,656.2753846153846,665.6376923076923,{"y":675,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,553.29,556.6023076923077,559.9146153846153,563.2269230769231,566.5392307692307,569.8515384615384,573.1638461538462,576.4761538461538,579.7884615384615,583.1007692307693,586.4130769230769,589.7253846153847,593.0376923076923,{"y":596.35,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,553.29,544.5753846153846,535.8607692307692,527.1461538461538,518.4315384615385,509.7169230769231,501.0023076923077,492.2876923076923,483.5730769230769,474.85846153846154,466.14384615384614,457.4292307692308,448.7146153846154,{"y":440,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":402.12,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":436.24,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":450.94,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":492.63,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":484.76,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":506.34,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":542.85,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":521.96,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 42,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":571.88,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":573.15,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 43,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":496.36,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":517.18,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":553.29,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$675.00

Average Price Target$596.35

Lowest Price Target$440.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$604

Buy

13.17%

Upside

Reiterated

06/27/25

Intuitive Surgical exhibits strong financial performance and a positive outlook from recent earnings guidance, which are the most significant factors driving the score. However, high valuation metrics and mixed technical signals moderate the overall score. Strategic leadership changes and capital management initiatives contribute positively, while international challenges pose potential risks.

Travis SteedBank of America Securities

Bank of America Securities

$650

Buy

21.79%

Upside

Reiterated

06/13/25

Intuitive Surgical's Growth Potential Outweighs Reprocessing Risks: Buy Rating Maintained

Larry BiegelsenWells Fargo

Wells Fargo

$559

Buy

4.74%

Upside

Reiterated

06/11/25

Analysts Conflicted on These Healthcare Names: Novavax (NASDAQ: NVAX) and Intuitive Surgical (NASDAQ: ISRG)

Lee HambrightBernstein

Bernstein

$675

Buy

26.47%

Upside

Reiterated

06/11/25

Bernstein Sticks to Their Buy Rating for Intuitive Surgical (ISRG)

Brandon VazquezWilliam Blair

William Blair

―

Buy

―

Reiterated

06/11/25

Intuitive Surgical's Strong Market Position and Future Prospects Justify Buy Rating Despite Remanufacturing Concerns

Matt MiksicBarclays

Barclays

$684→$635

Buy

18.98%

Upside

Reiterated

06/09/25

Barclays says pullback 'attractive' buying opportunity for Intuitive SurgicalBarclays says pullback 'attractive' buying opportunity for Intuitive Surgical

Imron ZafarDeutsche Bank

Deutsche Bank

$515→$440

Sell

-17.56%

Downside

Downgraded

06/09/25

Intuitive Surgical downgraded to Sell from Hold at Deutsche BankIntuitive Surgical downgraded to Sell from Hold at Deutsche Bank

Hans EngelErste Group

Erste Group

―

Buy

―

Upgraded

06/05/25

Intuitive Surgical upgraded to Buy from Hold at Erste GroupIntuitive Surgical upgraded to Buy from Hold at Erste Group

Unknown AnalystGoldman Sachs

Not Ranked

Goldman Sachs

$569→$636

Buy

19.17%

Upside

Reiterated

06/03/25

Goldman Sachs Sticks to Their Buy Rating for Intuitive Surgical (ISRG)

Joanne WuenschCiti

Citi

$590→$650

Buy

21.79%

Upside

Reiterated

05/23/25

Intuitive Surgical price target raised to $650 from $590 at CitiIntuitive Surgical price target raised to $650 from $590 at Citi

Richard NewitterTruist Financial

Truist Financial

―

Buy

―

Reiterated

05/16/25

Truist Financial Sticks to Their Buy Rating for Intuitive Surgical (ISRG)

David RescottRobert W. Baird

Robert W. Baird

$575

Buy

7.74%

Upside

Reiterated

05/15/25

Baird says CEO 'well-equipped' to further Intuitive Surgical positionBaird says CEO 'well-equipped' to further Intuitive Surgical position

Matthew TaylorJefferies

Jefferies

―

Hold

―

Reiterated

05/02/25

Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (NASDAQ: PRCT), Intuitive Surgical (NASDAQ: ISRG) and Bio-Rad Laboratories (NYSE: BIO)

Jayson BedfordRaymond James

Raymond James

$688→$592

Buy

10.92%

Upside

Reiterated

04/23/25

Intuitive Surgical (ISRG) PT Lowered to $592 at Raymond JamesRaymond James analyst Jayson Bedford lowered the price target on Intuitive Surgical (NASDAQ: ISRG) to $592.00 (from $688.00) while maintaining a Outperform rating.

Adam MaederPiper Sandler

Piper Sandler

$670→$575

Buy

7.74%

Upside

Reiterated

04/23/25

Analysts Offer Insights on Healthcare Companies: Becton Dickinson (NYSE: BDX), Intuitive Surgical (NASDAQ: ISRG) and Century Therapeutics (NASDAQ: IPSC)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$604

Buy

13.17%

Upside

Reiterated

06/27/25

Travis SteedBank of America Securities

Bank of America Securities

$650

Buy

21.79%

Upside

Reiterated

06/13/25

Intuitive Surgical's Growth Potential Outweighs Reprocessing Risks: Buy Rating Maintained

Larry BiegelsenWells Fargo

Wells Fargo

$559

Buy

4.74%

Upside

Reiterated

06/11/25

Analysts Conflicted on These Healthcare Names: Novavax (NASDAQ: NVAX) and Intuitive Surgical (NASDAQ: ISRG)

Lee HambrightBernstein

Bernstein

$675

Buy

26.47%

Upside

Reiterated

06/11/25

Bernstein Sticks to Their Buy Rating for Intuitive Surgical (ISRG)

Brandon VazquezWilliam Blair

William Blair

―

Buy

―

Reiterated

06/11/25

Intuitive Surgical's Strong Market Position and Future Prospects Justify Buy Rating Despite Remanufacturing Concerns

Matt MiksicBarclays

Barclays

$684→$635

Buy

18.98%

Upside

Reiterated

06/09/25

Barclays says pullback 'attractive' buying opportunity for Intuitive SurgicalBarclays says pullback 'attractive' buying opportunity for Intuitive Surgical

Imron ZafarDeutsche Bank

Deutsche Bank

$515→$440

Sell

-17.56%

Downside

Downgraded

06/09/25

Intuitive Surgical downgraded to Sell from Hold at Deutsche BankIntuitive Surgical downgraded to Sell from Hold at Deutsche Bank

Hans EngelErste Group

Erste Group

―

Buy

―

Upgraded

06/05/25

Intuitive Surgical upgraded to Buy from Hold at Erste GroupIntuitive Surgical upgraded to Buy from Hold at Erste Group

Unknown AnalystGoldman Sachs

Not Ranked

Goldman Sachs

$569→$636

Buy

19.17%

Upside

Reiterated

06/03/25

Goldman Sachs Sticks to Their Buy Rating for Intuitive Surgical (ISRG)

Joanne WuenschCiti

Citi

$590→$650

Buy

21.79%

Upside

Reiterated

05/23/25

Intuitive Surgical price target raised to $650 from $590 at CitiIntuitive Surgical price target raised to $650 from $590 at Citi

Richard NewitterTruist Financial

Truist Financial

―

Buy

―

Reiterated

05/16/25

Truist Financial Sticks to Their Buy Rating for Intuitive Surgical (ISRG)

David RescottRobert W. Baird

Robert W. Baird

$575

Buy

7.74%

Upside

Reiterated

05/15/25

Baird says CEO 'well-equipped' to further Intuitive Surgical positionBaird says CEO 'well-equipped' to further Intuitive Surgical position

Matthew TaylorJefferies

Jefferies

―

Hold

―

Reiterated

05/02/25

Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (NASDAQ: PRCT), Intuitive Surgical (NASDAQ: ISRG) and Bio-Rad Laboratories (NYSE: BIO)

Jayson BedfordRaymond James

Raymond James

$688→$592

Buy

10.92%

Upside

Reiterated

04/23/25

Adam MaederPiper Sandler

Piper Sandler

$670→$575

Buy

7.74%

Upside

Reiterated

04/23/25

Analysts Offer Insights on Healthcare Companies: Becton Dickinson (NYSE: BDX), Intuitive Surgical (NASDAQ: ISRG) and Century Therapeutics (NASDAQ: IPSC)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Intuitive Surgical

1 Month

xxx

Success Rate

15/21 ratings generated profit

Average Return

+4.32%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 71.43% of your transactions generating a profit, with an average return of +4.32% per trade.

3 Months

xxx

Success Rate

25/32 ratings generated profit

Average Return

+9.02%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 78.13% of your transactions generating a profit, with an average return of +9.02% per trade.

1 Year

Richard NewitterTruist Financial

Success Rate

32/37 ratings generated profit

Average Return

+28.76%

reiterated a buy rating last month

Copying Richard Newitter's trades and holding each position for 1 Year would result in 86.49% of your transactions generating a profit, with an average return of +28.76% per trade.

2 Years

xxx

Success Rate

34/37 ratings generated profit

Average Return

+67.32%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 91.89% of your transactions generating a profit, with an average return of +67.32% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ISRG Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

May 25

Jun 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ISRG has received 31 Buy Ratings, 3 Hold Ratings, and 1 Sell Ratings. ISRG average Analyst price target in the past 3 months is 596.35.

Each month's total comprises the sum of three months' worth of ratings.

ISRG Financial Forecast

ISRG Earnings Forecast

Next quarter’s earnings estimate for ISRG is $1.93 with a range of $1.87 to $2.12. The previous quarter’s EPS was $1.81. ISRG beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.17% of the time in the same period. In the last calendar year ISRG has Outperformed its overall industry.

ISRG Sales Forecast

Next quarter’s sales forecast for ISRG is $2.35B with a range of $2.29B to $2.40B. The previous quarter’s sales results were $2.25B. ISRG beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.52% of the time in the same period. In the last calendar year ISRG has Outperformed its overall industry.

ISRG Stock Forecast FAQ

What is ISRG’s average 12-month price target, according to analysts?

Based on analyst ratings, Intuitive Surgical’s 12-month average price target is 596.35.

What is ISRG’s upside potential, based on the analysts’ average price target?

Intuitive Surgical has 11.74% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ISRG a Buy, Sell or Hold?

Intuitive Surgical has a consensus rating of Strong Buy which is based on 18 buy ratings, 2 hold ratings and 1 sell ratings.

What is Intuitive Surgical’s price target?

The average price target for Intuitive Surgical is 596.35. This is based on 21 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $675.00 ,the lowest forecast is $440.00. The average price target represents 11.74% Increase from the current price of $533.71.

What do analysts say about Intuitive Surgical?

Intuitive Surgical’s analyst rating consensus is a Strong Buy. This is based on the ratings of 21 Wall Streets Analysts.

How can I buy shares of ISRG?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Intuitive Surgical (ISRG) Stock Forecast & Price Target

ISRG Analyst Ratings

ISRG Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Intuitive Surgical

ISRG Analyst Recommendation Trends

ISRG Financial Forecast

ISRG Earnings Forecast

ISRG Sales Forecast

ISRG Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts